Related Experiment Video
Updated: Dec 26, 2025

Colorimetric Analysis of Alkaline Phosphatase Activity in S. aureus Biofilm
Published on: April 12, 2019
Age-wise trends in alkaline phosphatase activity in 167,625 Chinese children aged 0-18 years
Kui-Lin Lü1, Shuang-Shuang Xie2, En Liu3
1Department of Pediatrics, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing 400037, PR China.
Insights
Alkaline phosphatase (ALP) levels in children aged 0-18 show distinct age-related patterns, peaking earlier in girls and differing between Chinese and German populations. These findings establish crucial reference values for pediatric clinical use.
Area of Science:
- Biochemistry
- Pediatrics
- Clinical Chemistry
Background:
- Alkaline phosphatase (ALP) is a key diagnostic biomarker in adults.
- Pediatric ALP activity fluctuates significantly with age and physiological changes, limiting its diagnostic utility without age-specific reference values.
Purpose of the Study:
- To investigate the age-specific dynamics of alkaline phosphatase (ALP) activity in children aged 0-18 years.
- To establish reliable reference values for pediatric ALP activity.
- To compare ALP activity patterns between Chinese and German children.
Main Methods:
- Analysis of 167,625 pediatric samples (0-18 years).
- ALP activity measured using the 4-nitrophenyl-1-phosphate disodium salt (4-NPP)-2-amino-2-methyl-1-propanol (AMP) method.
- Percentile curves generated using MATLAB and fitted with the LMS method, excluding patients with conditions affecting ALP.
Main Results:
- ALP activity peaks in boys aged 12-13 years and in girls aged 10-11 years.
- Activity declines in both sexes through adolescence.
- The peak ALP activity observed in Chinese children occurred earlier than in German children.
Conclusions:
- The study elucidates the age-dependent dynamics of ALP activity in Chinese children (0-18 years).
- Significant differences in ALP activity timing were noted between Chinese and German children.
- Provides essential reference data for pediatric clinical interpretation of ALP levels.
Objective:
Alkaline phosphatase (ALP) serves as a biomarker for diagnosing several types of diseases in adults; nonetheless, its use is restricted in children because of changes in ALP activity during different physiological phases. The present study aimed to investigate ALP activity and its dynamics in children of different ages to establish the reference values for ALP activity in children.
Methods:
Total 167,625 samples of children aged 0-18 years were enrolled in this study. ALP activity was measured using the 4-nitrophenyl-1-phosphate disodium salt (4-NPP)-2-amino-2-methyl-1-propanol (AMP) method with an automatic biochemical analyzer. Patients with known diagnoses that may affect ALP activity were excluded. A percentile curve was plotted using MATLAB software, and the curve was fitted using the skewness-median-coefficient of variation (LMS) method.
Results:
ALP activity reached the highest peak at 12-13 years of age and then gradually decreased to the lowest peak at 18-19 years of age in boys, whereas it reached the highest at 10-11 years and then gradually reduced to the lowest at 17-18 years in girls. Furthermore, the highest peak of ALP activity appeared substantially earlier in children of either sex in China than in those in Germany.
Conclusions:
We showed the dynamics of ALP activity in both boys and girls between the ages of 0 and 18 years in China and compared the difference in ALP activity between children in China and Germany. Our findings provide a reference for clinicians.
More Related Videos
06:51Physical Activity Measurement in Children Accepting Table Tennis Training
Published on: July 27, 2022
10:32Author Spotlight: Simple Establishment of a Vascularized Osteogenic Bone Marrow Niche Using Pre-Cast Poly(Ethylene Glycol) (PEG) Hydrogels in an Imaging Microplate
Published on: May 19, 2023
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test